Stanglmaier M - Search Results

1

Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies.

Schuster FR, Stanglmaier M, Woessmann W, Winkler B, Siepermann M, Meisel R, Schlegel PG, Hess J, Lindhofer H, Borkhardt A, Buhmann R. Schuster FR, et al. Among authors: stanglmaier m. Br J Haematol. 2015 Apr;169(1):90-102. doi: 10.1111/bjh.13242. Epub 2014 Dec 11. Br J Haematol. 2015. PMID: 25495919 Free article. Clinical Trial.

2

Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.

Buhmann R, Simoes B, Stanglmaier M, Yang T, Faltin M, Bund D, Lindhofer H, Kolb HJ. Buhmann R, et al. Among authors: stanglmaier m. Bone Marrow Transplant. 2009 Mar;43(5):383-97. doi: 10.1038/bmt.2008.323. Epub 2008 Oct 13. Bone Marrow Transplant. 2009. PMID: 18850012

3

Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels.

Stanglmaier M, Faltin M, Ruf P, Bodenhausen A, Schröder P, Lindhofer H. Stanglmaier M, et al. Int J Cancer. 2008 Sep 1;123(5):1181-9. doi: 10.1002/ijc.23626. Int J Cancer. 2008. PMID: 18546289

4

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells.

Nagy ZA, Hubner B, Löhning C, Rauchenberger R, Reiffert S, Thomassen-Wolf E, Zahn S, Leyer S, Schier EM, Zahradnik A, Brunner C, Lobenwein K, Rattel B, Stanglmaier M, Hallek M, Wing M, Anderson S, Dunn M, Kretzschmar T, Tesar M. Nagy ZA, et al. Among authors: stanglmaier m. Nat Med. 2002 Aug;8(8):801-7. doi: 10.1038/nm736. Epub 2002 Jul 8. Nat Med. 2002. PMID: 12101408

5

Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells.

Stanglmaier M, Reis S, Hallek M. Stanglmaier M, et al. Ann Hematol. 2004 Oct;83(10):634-45. doi: 10.1007/s00277-004-0917-0. Epub 2004 Aug 7. Ann Hematol. 2004. PMID: 15309525

6

The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains.

Stanglmaier M, Warmuth M, Kleinlein I, Reis S, Hallek M. Stanglmaier M, et al. Leukemia. 2003 Feb;17(2):283-9. doi: 10.1038/sj.leu.2402778. Leukemia. 2003. PMID: 12592324

7

Cloning, sequence determination and functional expression of the genes encoding adenovirus type-4 polymerase and the terminal protein precursor.

Stanglmaier M, Winnacker EL. Stanglmaier M, et al. Gene. 1996 Feb 12;168(2):177-82. doi: 10.1016/0378-1119(95)00801-2. Gene. 1996. PMID: 8654940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters